Physician

Alessandro Bellucci, MD

According to 2025 Medicare claims, Alessandro Bellucci, MD (NPI: 1962562017) practices nephrology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is NORTH SHORE-LIJ MEDICAL PC (NPI: 1053688572; TIN: 113506359) and primary practice location at 11021-5501. Bellucci is affiliated with the Northwell Health ACO (ACO ID: A3030), participating under the MSSP model.

Bellucci's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 167 traditional Medicare patients, billed 1,696 HCPCS/CPT codes, and received $33,549 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,497 prescription claims across 181 beneficiaries totaling $259,419 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 401 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $10,347 to $33,549. Similarly, Part D prescription costs have moved sharply higher in recent years, from $136,140 to $259,419. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	39	128	$10,347
2016	40	263	$11,427
2017	35	691	$13,484
2018	33	397	$10,821
2019	40	123	$10,988
2020	88	546	$20,180
2021	117	3,087	$30,759
2022	149	2,135	$31,710
2023	162	1,656	$31,294
2024	167	1,696	$33,549

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	888	$136,140
2016	45	772	$109,297
2017	40	657	$71,372
2018	37	586	$52,372
2019	35	609	$55,121
2020	69	761	$111,963
2021	91	834	$125,156
2022	118	980	$142,548
2023	169	1,315	$197,997
2024	181	1,497	$259,419

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	444	$17,828
2016	25	469	$14,363
2017	23	368	$12,142
2018	42	464	$22,105
2019	40	526	$28,483
2020	42	528	$25,657
2021	44	692	$23,334
2022	48	642	$21,315
2023	36	528	$12,109
2024	11	401	$7,673

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	18	22	$115
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	48	48	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	126	275	$79

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	81	4,985	$92,155
Lokelma	Sodium Zirconium Cyclosilicate	40	1,618	$31,884
Jardiance	Empagliflozin	28	1,560	$28,234
Cinacalcet Hcl	Cinacalcet Hcl	11	930	$3,063
Torsemide	Torsemide	124	7,540	$2,557

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	11	136	$1,823
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	84	$1,313
J7515	Cyclosporine, oral, 25 mg	N	N/R	18	$1,094
J7502	Cyclosporine, oral, 100 mg	N	N/R	11	$1,063
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	61	$1,035

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Alessandro Bellucci, MD?

Tedicare shows public-source Medicare data for Alessandro Bellucci, MD (NPI 1962562017), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alessandro Bellucci, MD have ACO affiliation data?

Alessandro Bellucci, MD is shown with ACO affiliation data for Northwell Health ACO (MSSP, ACO ID A3030).

What billing organization is linked to Alessandro Bellucci, MD?

Alessandro Bellucci, MD is linked to NORTH SHORE-LIJ MEDICAL PC (billing NPI 1053688572) in the available physician profile data.

Does Alessandro Bellucci, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.